|
|
|
Sponsors' & Exhibitors' Profile
| Platinum Sponsors |
|
About Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavours.
For more information please visit www.boehringer-ingelheim.com. |
|
Janssen
Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in metabolic diseases (including diabetes), cardiovascular, oncology, immunology, neuroscience, infectious diseases and vaccines and gastroenterology.
Janssen comprises companies with nearly 40,000 employees in more than 150 countries around the world. We work within and beyond our communities, globally, to bring innovative products, services and solutions to people throughout the world.
Janssen is one of the Johnson & Johnson Pharmaceutical Companies. Please visit www.janssen.com for more information.
LifeScan
Caring is at the core of everything we do at LifeScan. For over two decades, we have had an unwavering commitment to improving the quality of life for people with diabetes. Every day, millions of people worldwide depend on LifeScan’s OneTouch® Brand systems for simple testing and accurate results.
A Johnson & Johnson Company since 1986, LifeScan is headquartered in Milpitas, California. We also have manufacturing facilities in Puerto Rico and Scotland, and employ more than 2,500 people worldwide. |
|
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.
Novo Nordisk’s B shares are listed on NASDAQ Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). |
|
About Servier
Servier is France’s leading independent pharmaceutical company and the second largest French drug company worldwide. Research at Servier is focused on cardiovascular disease, neuropsychiatric disease, osteoporosis, cancer and metabolic diseases - of which diabetes is a major priority. Servier has been committed to optimisation of the treatment of type 2 diabetes for over 30 years, through the discovery of original antidiabetic agents and numerous activities promoting research and education. The key drug in Servier’s diabetes portfolio is Diamicron MR 60, which is indicated for the treatment of adults with type 2 diabetes.
For more information, please visit www.servier.com. |
| Gold Sponsors |
|
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio, and a continued commitment to providing real solutions – from medicines to support programs and more – to make lives better.
For more information, please visit www.lilly.com. |
|
About MSD
Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
For more information, visit www.msd.com or www.msd-singapore.com and connect with us on Twitter, Facebook and YouTube. |
| Silver Sponsor |
|
About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 45.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 35 years, the Accu-Chek brand has been dedicated to enabling people with diabetes to live life as normally and actively as possible as well as to empowering healthcare professionals to manage their patients’ condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management, spanning from blood glucose monitoring through information management to insulin delivery. The Accu-Chek brand encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs - leading to an improved medical outcome.
For more information, please visit www.accu-chek.com. |
| Bronze Sponsor |
|
AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care, specialty care-led and specialty care medicines that transform lives.
Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.
We operate in more than 100 countries and our innovative medicines are used by millions of patients worldwide. We want to be valued as a source of great medicines and trusted as a company that delivers business success responsibly. We are committed to operating with integrity and high ethical standards across all our activities.
We push the boundaries of science to deliver life-changing medicines. |
| Hospitality Suite Sponsor |
|
|
|
|
